These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 26428741

  • 21. Palivizumab and RSV prevention.
    Carnegie C.
    Arch Dis Child; 2000 Jul; 83(1):87. PubMed ID: 10960341
    [No Abstract] [Full Text] [Related]

  • 22. Nirsevimab-a breakthrough in respiratory syncytial virus bronchiolitis.
    Assad Z, Papenburg J, Ouldali N.
    Lancet Child Adolesc Health; 2024 Oct; 8(10):708-709. PubMed ID: 39208834
    [No Abstract] [Full Text] [Related]

  • 23. Effect of RSV bronchiolitis practice guidelines on resource utilization.
    Harrison AM, Boeing NM, Domachowske JB, Piedmonte MR, Kanter RK.
    Clin Pediatr (Phila); 2001 Sep; 40(9):489-95. PubMed ID: 11583047
    [Abstract] [Full Text] [Related]

  • 24. Respiratory syncytial virus bronchiolitis in children.
    Verger JT, Verger EE.
    Crit Care Nurs Clin North Am; 2012 Dec; 24(4):555-72. PubMed ID: 23089660
    [Abstract] [Full Text] [Related]

  • 25. Acute bronchiolitis.
    Teshome G, Gattu R, Brown R.
    Pediatr Clin North Am; 2013 Oct; 60(5):1019-34. PubMed ID: 24093893
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Viral bronchiolitis in young infants: new perspectives for management and treatment.
    Caballero MT, Polack FP, Stein RT.
    J Pediatr (Rio J); 2017 Oct; 93 Suppl 1():75-83. PubMed ID: 28859915
    [Abstract] [Full Text] [Related]

  • 28. The severity of respiratory syncytial virus bronchiolitis in young infants in the United Arab Emirates.
    Howidi M, Rajah J, Abushrar Z, Parsons H.
    J Trop Pediatr; 2007 Feb; 53(1):22-6. PubMed ID: 17008442
    [Abstract] [Full Text] [Related]

  • 29. Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases).
    DeVincenzo J.
    Adv Pediatr Infect Dis; 1997 Feb; 13():1-47. PubMed ID: 9544306
    [No Abstract] [Full Text] [Related]

  • 30. [Prevention and therapy of bronchiolitis: current status].
    León León MC, Dorao Martínez-Romillo P, García García S, Ruza Tarrío F.
    An Esp Pediatr; 1998 Nov; 49(5):451-5. PubMed ID: 9949584
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Respiratory syncytial virus infection in children.
    Dawson-Caswell M, Muncie HL.
    Am Fam Physician; 2011 Jan 15; 83(2):141-6. PubMed ID: 21243988
    [Abstract] [Full Text] [Related]

  • 33. The diagnostic and therapeutic approach to acute bronchiolitis in hospitalized children in Israel: a nationwide survey.
    Offer I, Ashkenazi S, Livni G, Shalit I.
    Isr Med Assoc J; 2000 Feb 15; 2(2):108-10. PubMed ID: 10804929
    [Abstract] [Full Text] [Related]

  • 34. [Management of bronchiolitis in the infant. Recommendations. Long text].
    Stagnara J, Balagny E, Cossalter B, Dommerges JP, Dournel C, Drahi E, Gauchez H, Guillot F, Javault D, Lagardère B, Le Masne A, Lesprit E, Maidenberg M, Maufroy D, Picherot G, Renaud H, Robert J, Undreiner F.
    Arch Pediatr; 2001 Jan 15; 8 Suppl 1():11S-23S. PubMed ID: 11232429
    [No Abstract] [Full Text] [Related]

  • 35. Risk factors for admission and the role of respiratory syncytial virus-specific cytotoxic T-lymphocyte responses in children with acute bronchiolitis.
    Jeena PM, Ayannusi OE, Annamalai K, Naidoo P, Coovadia HM, Guldner P.
    S Afr Med J; 2003 Apr 15; 93(4):291-4. PubMed ID: 12806723
    [Abstract] [Full Text] [Related]

  • 36. Potential mechanisms causing delayed effects of respiratory syncytial virus infection.
    Openshaw PJ.
    Am J Respir Crit Care Med; 2001 Mar 15; 163(3 Pt 2):S10-3. PubMed ID: 11254545
    [No Abstract] [Full Text] [Related]

  • 37. Ribavarin in ventilated respiratory syncytial virus bronchiolitis: a randomized, placebo-controlled trial.
    Khoshoo V, Edell D.
    Am J Respir Crit Care Med; 2000 Jul 15; 162(1):333-4. PubMed ID: 10903266
    [No Abstract] [Full Text] [Related]

  • 38. Treating acute bronchiolitis associated with RSV.
    Steiner RW.
    Am Fam Physician; 2004 Jan 15; 69(2):325-30. PubMed ID: 14765771
    [Abstract] [Full Text] [Related]

  • 39. Eosinophil-derived neurotoxin levels at 3 months post-respiratory syncytial virus bronchiolitis are a predictive biomarker of recurrent wheezing.
    Kim CK, Seo JK, Ban SH, Fujisawa T, Kim DW, Callaway Z.
    Biomarkers; 2013 May 15; 18(3):230-5. PubMed ID: 23557131
    [Abstract] [Full Text] [Related]

  • 40. Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae.
    Piedimonte G.
    Am J Respir Crit Care Med; 2001 Mar 15; 163(3 Pt 2):S18-21. PubMed ID: 11254547
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.